Shein and Zhiyuan Robotics Target Hong Kong Dual Listings in China Tech Capital Push

The Quick Take

• Shein is preparing for a Hong Kong IPO emphasizing its 'small batch fast return' technology model and long-term growth in the global fast fashion market
• Zhiyuan Robotics, a Chinese humanoid robot startup founded three years ago, is pursuing an A-share and Hong Kong dual listing under its '358 Grand Plan' targeting 100 billion yuan revenue by 2030
• Both IPOs reflect China's capital market push to list technology champions in Hong Kong, leveraging HKEx as a global investor access point for Chinese innovation companies

Shein, the world's largest online fast fashion platform, is reportedly advancing its Hong Kong IPO preparations with a pitch centered on its proprietary 'small batch fast return' supply chain technology — a model that allows it to test thousands of new designs weekly with minimal inventory risk before scaling successful items. The IPO narrative frames Shein not merely as a fast fashion retailer but as a technology-driven fashion logistics platform, a distinction designed to support a premium valuation multiple. The Hong Kong listing follows the collapse of an earlier planned US IPO amid regulatory and national security scrutiny, making HKEx the primary route for Shein to achieve public equity status.

Concurrently, Zhiyuan Robotics — founded in 2023 and focused on humanoid robots — is targeting a Hong Kong IPO to construct what it calls an 'A+H' dual capital layout, meaning parallel A-share (mainland) and H-share (Hong Kong) listings. The company's '358 Grand Plan' sets a 100 billion yuan revenue target by 2030, framing itself as a key commercialization vehicle for AI-driven physical robotics in China. The timing aligns with intense global investor interest in humanoid robotics following public demonstrations by Tesla, Figure, and 1X, positioning Zhiyuan as China's answer to the category. Its IPO would potentially value the company at a premium to pure-software AI peers given the hardware complexity of humanoid systems.

The forward signals for both listings include the HKEx IPO approval timeline and the reception from institutional investors across Asia, Europe, and the Middle East. The macro variable is Hong Kong's IPO market conditions: a continued recovery in HKEx trading volumes and valuations would support both listings, while any renewed regulatory friction between China and the West could chill institutional participation from US-based funds in Hong Kong IPOs. For the robotics sector specifically, watch for commercial deployment milestones from Zhiyuan — any publicly announced factory or logistics customer would significantly de-risk the investment case ahead of the listing.

Synthesized from 2 sources.